Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 56854Q101

Event date: 2017-12-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-373740
Form type
SC 13G/A
Filer
Bain Capital Life Sciences Fund, L.P.
CIK
CIK 1687968
Filed
Dec 19, 2017
Reporting period
Dec 18, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub